Clinical trial
Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux
NCT00609284 is registered in ClinicalTrials.gov with Groupe Oncologie Radiotherapie Tete et Cou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-erbitux
- Lead sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 15, 2008
- Completion date
- March 26, 2019
- Enrollment
- 406 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
hnscc